Skip to content
CEpartner4U
  • Welcome
  • About us
    • Team
    • Jobs
  • Services
    • AR/EC Rep
    • Regulatory affairs
    • Quality system
    • CE/QMS Entry Packages©
    • Clinical evaluation
    • Training
  • UKCApartner4U
  • Information
    • F.A.Q. AR/EC Rep
    • Links
  • Library
  • News
  • Network
  • Contact

About:m.vandervoort

Posts by m.vandervoort :

  • MedTech published recommendations on the use of guidance documents, 28 June 2022 in Uncategorized
  • Obligations for authorised representatives, importers and distributors, 26 May 2022 in Uncategorized
  • MDCG published a Q&A on the interface between Regulation (EU) 536/2014 on clinical trials for medicinal products for human use (CTR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), 25 May 2022 in Uncategorized
  • Commission publishes information on the status of the EU-Switzerland Mutual Recognition Agreement (MRA) for in vitro diagnostic medical devices, 23 May 2022 in Uncategorized
  • 3 New MDCG documents published, 20 May 2022 in Uncategorized
  • MDCG 2022-6 published on Guidance on significant changes regarding the transitional provision under Article 110(3) of the IVDR, 4 May 2022 in Uncategorized
  • Updated MDCG Joint Implementation Plan on IVDR, 1 April 2022 in Uncategorized
  • MDCG publishes revision 1 of 2019-9 about SSCP, 24 March 2022 in Uncategorized
  • MDCG 2022-4 published: Notified Body surveillance of MDR legacy devices, 16 February 2022 in Uncategorized
  • Publication in Official Journal of the European Union about the transitional periods of the IVDR, 28 January 2022 in Uncategorized
  • «
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • »

Stay informed

Please check your inbox or spam box to confirm

Copyright 2026 CEpartner4U | Esdoornlaan 13 | 3951 DB Maarn | The Netherlands | +31.6.516.536.26 | office@cepartner4u.com
  • enEnglish